Market

Posts net profit of Rs 20.3 crores as compared to Rs 18.7 crores for the preceding Jan-Mar quarter

IDPL, Gurgaon plant has been upgraded at the cost of Rs 3 crores as per 'Revised Sch -M' requirement and has obtained GMP…

Ajanta Pharma has received final approval for its three Abbreviated New Drug Application (ANDAs) by US FDA for Montelukast…

To forge a strategic partnership in a range of research areas and novel technologies in the field of pharma processes and product…

The IPO is an offer for sale (OFS) by Biocon of a part of its shareholding in Syngene

Policy makers disclosed initiatives, policies and schemes for betterment of the pharma sector

Focus on opening new stores as availability has substantially improved: Hansraj Gangaram Ahir

Sphaera Pharma (India), a subsidiary of Sphaera Pharma (Singapore), and the Drug Discovery Research Centre (DDRC) of the…

First-of-its-kind study ranks 40 pharma companies in India on their digital health

Sandoz India’s Turbhe plant to down shutters by December 2016